Ascentage Pharma Group International - Unsponsored ADR AAPG
14.86
(0.37)
(2.43%)
as of 25 Sep
- Market cap
- $1.4B
- P/E
- —
Follow AAPG
| Older periods | Dec '24 | Jun '25 | Dec '25 | Jun '26 | |
|---|---|---|---|---|---|
|
+2 more TTM periods Free account |
— | — | 0.00% | 0.00% | |
| — | — | 0.00% | 0.00% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
— | — | 0.00 | 0.00 | |
Free Cash Flow |
— | — | (347.72) | (328.87) | |
Capital Expenditures |
— | — | (15.89) | (11.29) | |
Piotroski F-Score |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Cash ROIC |
0.00% | 0.00% | (40.12%) | (47.30%) | |
Accounts Receivable Turnover |
— | — | 0.00 | 0.00 | |
Accounts Payable Turnover |
— | — | 0.00 | 0.00 | |
Inventory Turnover |
— | — | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
— | — | 0.00 | 0.00 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
— | — | 0.00 | 0.00 | |
Operating CF per Share |
— | — | 0.00 | 0.00 | |
Capex per Share |
— | — | 0.00 | 0.00 | |
Capex to Sales |
— | — | 0.00 | 0.00 |
Columns are period end dates